Subscribe to Newsletter
Techniques & Tools Sample Preparation, Mass Spectrometry, Metabolomics & Lipidomics, Proteomics, Clinical, Data Analysis

What You’ve Been Reading...

1. “A great deal of scientific literature appears to be invisible to the research community unless it is electronically accessible – certain research projects are therefore in danger of missing critical information or repeating experiments that have already been undertaken. We should not re-invent the wheel.”

Robert Trengove, Tools of the Metabolomics Trade

2. “It is clear that errors made in sampling, sample preparation or sample introduction (injection) cannot be corrected by using even the most advanced MS systems.”

Frank David, Three Wizards of Sample Preparation

3. “We need new bioinformatic approaches to combine the proteomic data we generate with other omics data, particularly genomic, but also, metabolomic and lipidomic.”

Barry Karger, Three Gurus of Proteomics

4. “The Moore’s Law-esque advancement in our ability to identify and quantify proteins over the last 20 years is probably one of the few areas where end-users in a field have fully acknowledged the fact that industry has driven much of
the progress.”

Ian Jardine, Building Mass Spectrometry from the Inside

1214-205-1-345
1214-205-2-345
1214-205-3-345
1214-205-4-345

5. “MS imaging technology has matured enough to be applied in the clinic, but small-scale efforts will lead to disappointments; a large-scale infrastructure is needed to take full advantage of the benefits. Investment is essential, as is the concerted effort of all involved.”

Ron Heeren, MS Imaging Targets the Clinic

6. “What is especially interesting is that these biomarkers reflect the risk for dying from very different types of diseases, such as heart disease or cancer. They seem to be signs of a general frailty in the body.”

Johannes Kettunen, Death Card

7. “I’ve noticed that all around me the ‘chemistry’ part of my field is less and less obvious – analytical chemistry has become analytical science (as emphasized by the title of this very magazine!). The problem is that you can’t simply forget about the exciting and interesting chemistry occurring (nowadays very much in the background) to enable a particular analytical method.”

W. Franklin Smyth, Back to School for Pharmaceutical Analysis

8. “A specific sampling process can either be representative – or not. If sampling is not representative, we have only undefined, mass-reduced lumps of material without provenance (called ‘specimens’ in the theory of sampling) that are not actually worth analyzing.”

Kim H. Esbensen and Claas Wagner, Why We Need the Theory of Sampling

1214-205-5-345
1214-205-6-345
1214-205-7-345
1214-205-8-345

9. “Organic contaminants can undergo bio-transformation once they are in the environment; for example, a pharmaceutical rarely exits the human body in its original form but rather as a more polar metabolite that enters the environment through the sewage system. Such transformation products should get more attention. Are they present and, if so, at what levels and risk?”

Annemieke Kolkman, H2OK?

10. “The big change in analytics is the migration from generating analytical data to generating actionable, affordable information.”

George Whitesides, Using Simplicity

1214-205-9-345
1214-205-10-345
Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Rich Whitworth

Rich Whitworth completed his studies in medical biochemistry at the University of Leicester, UK, in 1998. To cut a long story short, he escaped to Tokyo to spend five years working for the largest English language publisher in Japan. "Carving out a career in the megalopolis that is Tokyo changed my outlook forever. When seeing life through such a kaleidoscopic lens, it's hard not to get truly caught up in the moment." On returning to the UK, after a few false starts with grey, corporate publishers, Rich was snapped up by Texere Publishing, where he spearheaded the editorial development of The Analytical Scientist. "I feel honored to be part of the close-knit team that forged The Analytical Scientist – we've created a very fresh and forward-thinking publication." Rich is now also Content Director of Texere Publishing, the company behind The Analytical Scientist.

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register